highlight
ntz
amplifi
rna
sensor
type
interferon
activ
induc
express
ntz
inhibit
infecti
ebola
viru
ebov
via
rigi
pkr
ntz
inhibit
second
negativestrand
rna
viru
vsv
via
rigi
pkr
ntz
hold
promis
oral
therapi
ebov
jasenoski
et
al
iscienc
show
us
food
drug
administrationapprov
oral
drug
nitazoxanid
ntz
broadli
amplifi
host
innat
immun
respons
virus
inhibit
ebola
viru
ebov
replic
find
ntz
enhanc
retinoicacidinduc
protein
rigi
likereceptor
mitochondri
antivir
signal
protein
interferon
regulatori
factor
interferon
activ
induc
transcript
antivir
phosphatas
ntz
significantli
inhibit
ebov
replic
human
cell
effect
rigi
protein
kinas
r
pkr
suggest
counteract
ebov
protein
abil
block
rigi
pkr
sens
ebov
ntz
also
inhibit
second
negativestrand
rna
viru
vesicular
stomat
viru
vsv
rigi
pkr
consist
vsv
distinct
host
innat
immun
evas
mechan
thu
ntz
counteract
vari
virusspecif
immun
evas
strategi
gener
enhanc
rna
sens
interferon
axi
trigger
foreign
cytoplasm
rna
exposur
hold
promis
oral
therapi
ebov
pathogen
virus
evolv
divers
array
mechan
avoid
impair
host
innat
immun
antivir
respons
unterholzn
almin
particularli
evad
pathway
result
type
interferon
ifn
product
signal
garciasastr
exampl
ebola
viru
ebov
reli
structur
protein
inhibit
viral
doublestrand
rna
dsrna
sens
retinoicacidinduc
protein
rigi
cardena
et
al
leung
et
al
luthra
et
al
ifninduc
doublestrand
ds
rna
sensor
protein
kinas
r
pkr
feng
et
al
schumann
et
al
thu
avoid
trigger
amplif
host
type
ifn
respons
critic
role
play
product
ebov
infect
underscor
find
mutat
introduc
disrupt
abil
sequest
viral
rna
intermedi
affect
function
ebov
replic
result
increas
type
ifn
induct
vitro
sever
attenu
viral
growth
vivo
mice
hartman
et
al
guinea
pig
hostdirect
therapi
could
overcom
potent
ebov
immun
evas
strategi
would
thu
particularli
use
nitazoxanid
ntz
oral
us
food
drug
administr
fda
approv
drug
use
million
adult
children
sinc
minim
advers
side
effect
treatment
giardiaand
cryptosporidiumassoci
diarrhea
includ
patient
coinfect
hiv
doumbo
et
al
hussar
rossignol
et
al
ntz
circul
metabolit
tizoxanid
tiz
also
report
inhibit
divers
array
virus
tissu
cultur
small
anim
model
rossignol
human
ntz
reduc
symptom
durat
uncompl
influenza
haffizulla
et
al
viral
gastroenter
rossignol
elgohari
rotavir
diarrhea
sever
mechan
propos
contribut
ntz
activ
specif
virus
ashiru
et
al
la
frazia
et
al
li
et
al
piacentini
et
al
rossignol
et
al
sekiba
et
al
includ
studi
show
enhanc
induct
ifnstimul
gene
isg
express
ntz
gekong
et
al
petersen
et
al
trabattoni
et
al
studi
show
weak
associ
ntz
pkr
activ
ashiru
et
al
elazar
et
al
howev
function
link
ntz
antivir
activ
specif
isg
pkr
demonstr
molecular
mechan
underli
broadspectrum
antivir
effect
host
cell
remain
unknown
show
treatment
cell
ntz
result
broad
amplif
host
innat
immun
respons
includ
increas
rigilik
receptor
rlr
activ
respons
stimul
cytoplasm
dsrna
enhanc
mitochondri
antivir
signal
protein
mav
interferon
regulatori
factor
activ
transcript
induct
antivir
phosphatas
base
data
hypothes
ntz
could
limit
overcom
ebov
abil
evad
detect
critic
innat
immun
sensor
follow
viral
entri
concentr
reflect
routin
oral
dose
parasit
infect
ntz
significantli
inhibit
ebov
replic
cell
furthermor
use
crisprdead
promot
target
ablat
express
individu
host
factor
show
ntz
inhibitori
effect
ebov
reli
rigi
pkr
indic
ntz
overcom
ebov
abil
prevent
viral
detect
cytoplasm
sensor
also
show
ntz
significantli
inhibit
second
negativestrand
rna
viru
vesicular
stomat
viru
vsv
distinct
mechan
involv
rigi
pkr
consist
differ
innat
immun
evas
strategi
employ
vsv
compar
ebov
thu
ntz
establish
broad
antivir
milieu
rapidli
amplifi
upon
viral
infect
capabl
counteract
vari
virusspecif
immun
evas
strategi
employ
ebov
vsv
effect
easili
deploy
oral
drug
treat
prevent
infect
ebov
caus
death
west
african
ebov
epidem
shiwani
et
al
claim
live
date
juli
current
outbreak
democrat
republ
congo
claud
et
al
world
health
organ
demonstr
ntz
significantli
inhibit
ebov
replic
vitro
suggest
ntz
could
potenti
role
treatment
acut
ebov
diseas
prevent
ebov
infect
expos
healthi
individu
erad
ebov
reservoir
persist
immuneprivileg
site
patient
cure
ebov
diseas
deen
et
al
provid
impetu
test
ntz
anim
model
ebov
infect
demonstr
vivo
efficaci
test
whether
ntz
enhanc
sens
rlr
pathway
overexpress
fulllength
rigi
melanoma
differentiationassoci
protein
two
major
rlr
protein
human
embryon
kidney
hek
cell
cotransfect
ifnb
promoterdriven
luciferas
report
plasmid
ifnb
luc
examin
whether
ntz
augment
ifnb
promot
activ
presenc
absenc
viral
nucleic
acid
analog
synthet
dsrna
poli
c
ntz
pretreat
enhanc
poli
cstimul
ifnb
promot
activ
rigi
figur
left
figur
right
overexpress
cell
dosedepend
manner
figur
case
overexpress
ntz
effect
ifnb
report
gene
activ
evid
even
absenc
poli
c
treatment
figur
right
rigi
differenti
recogn
distinct
viral
rna
signatur
kato
et
al
rigi
preferenti
recogn
triphosphosphoryl
short
dsrna
structur
typic
gener
negativestrand
rna
virus
wherea
recogn
longer
dsrna
structur
kato
et
al
schlee
et
al
precis
distinguish
ntz
effect
rna
sensor
next
test
effect
ntz
specif
rigi
stimulu
use
short
bp
phosphoryl
synthet
dsrna
peisley
et
al
found
ifnb
report
activ
also
significantli
enhanc
ntz
rigioverexpress
cell
stimul
figur
left
panel
furthermor
endogen
ifnb
mrna
synthesi
significantli
enhanc
ntz
pretreat
stimul
cell
figur
right
panel
next
test
abil
ntz
pretreat
activ
ifnb
report
gene
activ
cell
cotransfect
plasmid
overexpress
mav
adaptor
protein
rigi
signal
kawai
et
al
meylan
et
al
seth
et
al
xu
et
al
ifnb
luc
activ
strongli
enhanc
ntz
mavsoverexpress
cell
even
absenc
cellular
stimul
reach
increas
concentr
mm
ntz
figur
report
addit
prevent
phosphoryl
activ
block
rigi
viral
rna
sens
ebov
also
prevent
phosphoryl
directli
block
access
kinas
unphosphoryl
prin
et
al
determin
ntz
directli
augment
activ
next
transfect
cell
plasmid
encod
phosphomimet
abl
drive
ifnb
mrna
express
absenc
proxim
compon
rlr
signal
pathway
lin
et
al
shown
figur
ntz
enhanc
ifnb
report
activ
dosedepend
manner
furthermor
also
found
ntz
enhanc
type
ifninduc
transcript
isg
figur
thu
ntz
broadli
enhanc
signal
downstream
rlr
ifnb
signal
pathway
addit
act
agonist
viral
rna
sensor
act
proxim
part
pathway
cytoplasm
data
ntz
broadli
enhanc
antivir
sens
via
cytoplasm
rlr
pathway
amplifi
type
ifninduc
gene
express
includ
gene
synthesi
previous
shown
inhibit
ebov
infect
huang
et
al
led
us
specul
ntz
may
overcom
ebov
capac
evad
host
rna
sens
skirt
trigger
type
ifn
respons
basler
et
al
basler
et
al
cardena
et
al
hartman
et
al
leung
et
al
luthra
et
al
thu
favor
host
control
viru
test
hypothesi
examin
abil
ntz
inhibit
infecti
ebov
growth
human
pulmonari
epitheli
cell
vitro
biosafeti
level
condit
use
isol
infecti
ebov
origin
outbreak
democrat
republ
congo
kikwit
cell
pretreat
mm
ntz
toxic
cell
see
figur
h
infect
ebov
moi
shown
figur
vehicleonli
treat
cell
ebov
growth
increas
log
unit
h
postinfect
contrast
time
frame
ebov
growth
complet
inhibit
cell
treat
mm
ntz
p
drop
log
unit
initi
inoculum
titer
cell
treat
mm
ntz
p
note
mm
concentr
ntz
either
well
equival
peak
plasma
level
mm
activ
metabolit
tiz
observ
human
ingest
mg
ntz
twice
day
typic
oral
regimen
cryptosporidi
diarrhea
romark
begin
character
mechan
involv
ntz
antivir
activ
next
test
ntz
effect
second
rna
viru
rhabdoviru
vsv
like
ebov
member
order
mononegaviral
also
allow
test
biosafeti
level
condit
ntz
pretreat
cell
h
inhibit
growth
firefli
luciferaseexpress
vsv
vsvluc
report
viru
cureton
et
al
cell
greater
inhibit
vsvluc
achiev
ntz
concentr
mm
inhibit
obtain
mm
figur
left
given
import
rigi
pkr
ebov
evas
host
antivir
respons
cardena
et
al
feng
et
al
leung
et
al
luthra
et
al
schumann
et
al
report
ntz
weakli
induc
autophosphoryl
pkr
ashiru
et
al
elazar
et
al
next
sought
determin
role
molecul
ntz
antivir
activ
use
vsv
model
system
tradit
short
hairpin
rna
shrna
base
method
gene
knockdown
includ
cell
associ
nonspecif
type
ifn
induct
shrna
reduc
shrna
activ
respons
type
ifn
stimul
machitani
et
al
chose
knockdown
rigi
pkr
express
cell
target
dead
gene
promot
see
transpar
method
figur
grna
target
sequenc
figur
protein
knockdown
effici
rigi
deplet
ntz
concentr
test
inhibit
mm
ntz
crisprctrl
cell
versu
mm
ntz
crisprpkr
cell
figur
right
panel
indic
ntz
suppress
vsv
replic
depend
pkr
phosphatas
select
promot
ifnb
translat
context
host
global
translat
shutdown
follow
pkrdepend
phosphoryl
stress
pathway
activ
dalet
et
al
ntz
previous
shown
induc
low
level
endoplasm
reticulum
stress
ashiru
et
al
promot
translat
transcript
factor
elazar
et
al
translat
inhibit
transcript
activ
gene
express
hendershot
thu
investig
whether
ntz
affect
express
treat
cell
increas
concentr
ntz
h
measur
mrna
level
ntz
strongli
induc
mrna
synthesi
ntz
concentrationdepend
manner
figur
note
maxim
transcript
detect
h
postntz
stimul
cell
shown
investig
whether
particip
ntz
inhibitori
effect
vsv
knock
cell
use
strategi
describ
see
transpar
method
figur
infect
cell
figur
left
panel
vsvluc
report
viru
deplet
result
signific
increas
vsv
infectiongrowth
figur
right
panel
mm
ntz
data
point
similar
previous
report
find
vsv
mous
embryon
fibroblast
minami
et
al
furthermor
deplet
reduc
vsv
sensit
ntz
inhibit
mm
ntz
crisprctrl
cell
versu
mm
ntz
cell
figur
ntz
strongli
inhibit
vsv
infectionrepl
cell
deplet
rigi
pkr
impair
antivsv
activ
ntz
left
panel
cell
treat
ntz
indic
concentr
h
infect
vsv
firefli
luciferas
report
cureton
et
al
h
cell
harvest
firefli
luciferas
activ
measur
luminesc
assay
mean
standard
deviat
three
independ
experi
perform
duplic
shown
right
panel
cell
treat
vehicl
ntz
indic
concentr
h
cell
harvest
expos
mm
propidium
iodid
min
subject
flow
cytometri
figur
right
panel
indic
ntz
antivsv
activ
also
depend
abil
induc
express
addit
enhanc
rigi
function
taken
togeth
although
rigi
pkr
play
role
host
inhibit
vsv
rigi
pkr
involv
ntzmediat
repress
viru
next
analyz
ebov
replic
pkrkd
cell
biosafeti
level
condit
determin
individu
role
antivir
protein
restrict
ebov
growth
rigi
pkr
deplet
led
significantli
increas
ebov
kikwit
replic
figur
increas
greater
log
unit
h
postinfect
compar
control
cell
figur
right
experi
demonstr
import
factor
host
control
ebov
infect
contrast
although
deplet
result
higher
ebov
titer
h
impact
ebov
growth
h
postinfect
figur
right
thu
unlik
found
vsv
play
limit
role
restrict
ebov
growth
cell
determin
rigi
pkr
target
ntz
requir
inhibitori
effect
upon
ebov
next
pretreat
nonspecif
control
cell
pkrkd
cell
line
mm
ntz
h
infect
ebov
kikwit
moi
shown
figur
left
reduct
log
chang
b
figur
ntz
requir
pkr
rigi
full
inhibit
ebov
replic
cell
knockdown
rigi
pkr
cell
augment
ebov
replic
wherea
knockdown
modest
effect
ebov
growth
cell
mocktreat
treat
mm
ntz
h
infect
ebov
moi
presenc
pretreat
ntz
supernat
supernat
harvest
h
clarifi
ebov
plaqueform
unit
pfu
calcul
plaqu
assay
titer
display
linear
left
log
right
scale
clariti
p
p
b
compar
control
cell
ntz
inhibit
ebov
replic
impair
rigikd
pkrkd
cell
affect
knockdown
cell
mocktreat
treat
mm
ntz
h
infect
ebov
moi
presenc
pretreat
ntz
supernat
supernat
harvest
h
clarifi
ebov
pfu
calcul
plaqu
assay
titer
display
linear
left
log
right
scale
clariti
ntz
antiebov
activ
crisprpkrkd
cell
h
postinfect
compar
crisprcontrol
cell
indic
pkr
activ
play
critic
role
ntz
efficaci
ebov
rigi
deplet
also
result
appreci
although
lesser
reduct
ebov
sensit
ntz
h
postinfect
figur
contrast
deplet
littl
effect
ntz
abil
inhibit
ebov
growth
figur
shown
fdaapprov
small
molecul
drug
ntz
broadli
amplifi
cytoplasm
rna
sens
type
ifn
pathway
strongli
inhibit
replic
ebov
vsv
data
indic
ntz
amplif
rigi
pkr
activ
overcom
ebov
abil
prevent
trigger
critic
host
antivir
factor
contrast
case
vsv
ntzmediat
amplif
rigi
signal
induct
express
contribut
drug
antivsv
activ
thu
wide
array
innat
immun
activ
ntz
amplifi
provid
cell
capac
resist
product
infect
divers
virus
like
ebov
vsv
engag
distinct
host
evas
mechan
block
rigidriven
type
ifn
product
pkr
activ
sequest
dsrna
intermedi
bind
pkrrigi
activ
pact
bale
et
al
cardena
et
al
feng
et
al
leung
et
al
luthra
et
al
schumann
et
al
furthermor
mutat
dsrnabind
pocket
ebov
found
increas
type
ifn
induct
vitro
sever
attenu
viral
growth
vivo
hartman
et
al
prin
et
al
howev
rel
import
individu
dsrnatrigg
cytoplasm
sensor
control
ebov
replic
clearli
delin
data
show
knockdown
either
rigi
pkr
cell
lead
signific
increas
ebov
replic
log
h
directli
demonstr
host
molecul
contribut
control
ebov
growth
fact
wildtyp
clinic
ebov
isol
intact
part
genom
still
suscept
effect
rigi
pkr
underscor
critic
role
play
factor
host
control
ebov
furthermor
data
show
ntz
efficaci
ebov
reduc
host
cell
express
either
pkr
rigi
ablat
indic
abil
ntz
increas
activ
pkr
rigi
earli
stage
ebov
infect
tip
balanc
favor
host
blunt
abil
suppress
innat
immun
respons
ntz
also
suppress
vsv
replic
antivir
efficaci
markedli
reduc
upon
deplet
rigi
cell
howev
unlik
observ
ebov
knockdown
pkr
effect
ntz
inhibit
vsv
furthermor
absenc
ntz
found
knockdown
pkr
result
signific
milder
increas
vsv
growth
rel
robust
increas
ebov
replic
observ
pkr
express
ablat
note
vsv
matrix
protein
block
host
cell
type
ifn
respons
independ
pkr
inhibit
global
mrna
synthesi
nuclear
export
well
inhibit
global
host
protein
synthesi
ahm
et
al
black
lyle
connor
lyle
ferran
lucaslenard
von
kobb
et
al
vsv
matrix
protein
shut
host
cell
translat
primarili
induc
dephosphoryl
initi
complex
compon
lyle
howev
also
becom
phosphoryl
later
stage
vsv
infect
lead
addit
neg
effect
host
protein
synthesi
includ
type
ifn
product
well
viral
protein
synthesi
connor
lyle
shown
ntz
induc
transcript
translat
phosphatas
revers
phosphoryl
novoa
et
al
shown
critic
restor
translat
ifnb
select
cytokin
virusinfect
cell
clavarino
et
al
clavarino
et
al
dalet
et
al
given
deplet
reduc
ntz
activ
vsv
data
suggest
ntz
induct
amplifi
ntzaugment
rigi
signal
provid
cell
capac
mount
innat
immun
respons
suffici
overcom
vsv
matrix
protein
inhibitori
effect
upon
protein
synthesi
data
also
show
activ
factor
downstream
rlr
amplifi
ntz
overexpress
mav
constitut
phosphoryl
activ
amplifi
respons
ntz
stimul
result
increas
type
ifn
promot
activ
ntz
also
enhanc
type
ifninduc
mrna
synthesi
isg
critic
restrict
factor
ebov
huang
et
al
vsv
huang
et
al
weidner
et
al
shown
inhibit
vsv
infect
staeh
pavlov
thu
ntz
abil
amplifi
proxim
distal
aspect
viral
rna
sens
type
ifn
pathway
allow
broad
effect
antivir
respons
develop
cell
immedi
viral
target
neighbor
cell
yet
infect
although
three
previou
report
suggest
isg
induc
ntz
metabolit
tiz
play
antivir
role
direct
function
impact
ntz
tiz
upon
gene
respect
inhibit
viral
growth
shown
exampl
one
report
describ
increas
averag
express
panel
isg
peripher
blood
mononuclear
cell
pbmc
treat
low
concentr
mm
ntz
unspecifi
time
function
demonstr
individu
isg
affect
replic
viru
ntztreat
cell
petersen
et
al
anoth
articl
report
treatment
human
monocytederiv
macrophag
mdm
ntz
h
induc
express
isg
tetherin
although
author
associ
ntz
inhibit
hiv
mdm
function
demonstr
provid
show
molecul
play
role
ntz
antihiv
activ
gekong
et
al
third
studi
report
tiz
treatment
human
pbmc
day
induc
set
ifn
isg
approxim
compar
untreat
pbmc
slightli
greater
increas
averag
observ
context
hiv
infect
includ
respect
howev
function
link
isg
identifi
ntz
inhibit
hiv
replic
made
mechan
respons
investig
trabattoni
et
al
contrast
studi
biochem
gene
knockdown
approach
demonstr
ntz
treatment
result
broad
amplif
rlr
pathway
compon
primari
driver
type
ifn
product
isg
induct
amplifi
type
ifn
signal
furthermor
function
link
rigi
pkr
ntz
antivir
activ
ebov
function
link
rigi
ntz
activ
vsv
use
knockdown
molecul
host
cell
also
previous
report
ntz
induc
phosphoryl
pkr
differ
cell
line
howev
weak
ntzinduc
pkr
phosphoryl
observ
one
studi
h
mm
ntz
exposur
human
hepatoma
cell
harbor
hepat
c
viru
hcv
replicon
elazar
et
al
h
bovin
kidney
cell
line
mm
mm
ntz
anoth
studi
ashiru
et
al
furthermor
report
direct
function
link
put
pkr
phosphoryl
ntz
antivir
activ
demonstr
thu
leav
unverifi
function
import
pkr
phosphoryl
statu
ntz
abil
suppress
replic
pkrsensit
virus
contrast
demonstr
effect
ntz
ebov
growth
markedli
impair
cell
pkr
express
ablat
directli
link
ntz
pretreat
h
ebov
infect
pkr
restrict
ebov
growth
synthet
rlr
agonist
treatment
virus
gener
much
interest
yong
luo
howev
rlr
express
human
tissu
inflammatori
respons
induct
highli
variabl
person
person
concern
therapeut
approach
employ
rna
agonist
associ
unaccept
inflammatori
side
effect
elion
cook
intriguingli
ntz
use
extens
excel
safeti
profil
adult
children
treatment
parasit
infect
doumbo
et
al
hussar
rossignol
et
al
viral
diseas
hcv
rossignol
et
al
rossignol
et
al
influenza
haffizulla
et
al
notabl
find
indic
ntz
modul
innat
immun
respons
pathogen
enter
suscept
target
cell
amplif
natur
immun
control
viral
infect
need
case
virus
like
ebov
employ
immun
evas
mechan
avoid
trigger
innat
immun
respons
therapeut
profil
attract
although
identif
ntz
upstream
target
outsid
scope
articl
anticip
studi
underway
great
valu
unravel
host
pathway
lead
cellintrins
control
ebola
final
studi
present
suggest
valid
vivo
anim
model
ntz
could
potenti
use
ebov
diseas
monotherapi
adjuv
therapi
agent
specif
target
ebov
compon
furthermor
ntz
may
also
prove
valuabl
strategi
prevent
ebov
infect
erad
ebov
reservoir
persist
patient
surviv
ebov
diseas
although
ntz
fda
approv
treatment
cryptosporidi
diarrhea
welltoler
medic
limit
data
present
regard
ntz
inhibit
ebov
base
vitro
studi
yet
establish
ntz
efficaci
ebov
vivo
anim
model
furthermor
detail
investig
ntz
upstream
target
regul
immun
respons
describ
outsid
scope
articl
subject
futur
studi
vivo
test
ntz
ebov
method
found
accompani
transpar
method
supplement
file
supplement
inform
found
onlin
http
indebt
walli
annenberg
john
moor
critic
support
make
studi
possibl
work
fund
grant
annenberg
foundat
gift
john
moor
grant
nih
ragon
institut
aeg
nih
sh
twg
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
also
thank
jame
leduc
jame
hodg
advic
martin
dorf
gift
vsv
luciferas
report
viru
renat
hellmiss
artwork
jame
falvo
critic
read
manuscript
rnamedi
stimul
rlr
pathway
hek
maintain
plate
dulbecco
modifi
eagl
medium
cellgro
supplement
heatinactiv
fetal
calf
serum
fb
next
day
cell
transfect
ng
plasmid
encod
rigi
empti
vector
control
ahmad
et
al
wu
et
al
togeth
ng
promoterdriven
firefli
luciferas
report
plasmid
ng
cmv
promoterdriven
renilla
luciferas
report
plasmid
life
technolog
medium
chang
hour
posttransfect
dmem
contain
fb
indic
concentr
ntz
experi
involv
ntz
perform
manner
order
reduc
impact
serum
protein
ntz
function
tissu
cultur
ntz
highli
proteinbound
stocki
et
al
four
hour
addit
ntz
sigma
stabli
coexpress
guid
rna
specif
promot
gene
encod
pkr
ii
rigi
iii
lentivir
vector
construct
encod
ef
promoterdriven
cassett
promot
grna
transcript
see
supp
fig
base
similar
approach
laboratori
use
previous
chow
et
al
individu
grna
sequenc
obtain
crispr
design
program
crisprmitedu
shown
supplement
figur
along
site
individu
gene
promot
target
control
lentivir
vector
encod
promoterdriven
scrambl
grna
match
genom
sequenc
also
construct
design
crisprcontrol
gener
cell
stabl
knock
specif
gene
cell
transduc
control
genespecif
lentivirus
posit
transduc
cell
select
puromycin
week
describ
previous
chow
et
al
efficaci
knockdown
evalu
analyz
gene
express
follow
mock
stimul
stimul
ngml
human
hour
crisprcontrol
crisprrigi
crisprpkr
cell
ntz
hour
crisprcontrol
cell
rna
isol
revers
transcrib
use
anchor
oligodt
prime
cdna
measur
use
standard
qpcr
methodolog
normal
housekeep
gene
cyclophilin
b
primer
shown
legend
fig
crispr
cell
line
cultur
complet
media
assess
abil
ntz
treatment
inhibit
replic
authent
ebov
cell
infect
cell
duplic
zair
ebolaviru
kikwit
strain
ebov
hour
fb
cell
treat
ntz
hour
ebov
infect
pretreat
supernat
ntztreat
cell
remov
use
make
ebov
inocula
per
condit
cell
inocul
moi
rock
one
hour
inocula
left
cell
fresh
media
contain
ntz
ad
supernat
collect
hour
post
infect
analyz
product
infecti
viru
plaqu
assay
analysi
cell
knock
pkr
ii
rigi
iii
use
assess
mechan
ntz
ebov
inhibit
gene
analysi
infect
cell
duplic
zair
ebolaviru
kikwit
strain
ebov
hour
fb
cell
treat
ntz
hour
ebov
infect
pretreat
supernat
ntztreat
cell
remov
use
make
ebov
inocula
per
condit
cell
inocul
moi
rock
one
hour
inocula
left
cell
fresh
media
contain
ntz
ad
supernat
collect
hour
post
infect
analyz
product
infecti
viru
plaqu
assay
analysi
viru
titrat
perform
vero
cell
supernat
collect
increas
tenfold
dilut
sampl
adsorb
cell
monolay
duplic
well
limit
detect
assay
plaqu
form
unit
per
millilit
